Showing results (411-420 of 741) with videos related to
Sort By:
Pageof 75
Vaccine|January 27, 2004
Safety profile of recombinant canarypox HIV vaccinesGuy de Bruyn, Anthony J Rossini, Ya-Lin Chiu, et al.The Journal of Infectious Diseases|November 18, 2019
Cytomegalovirus Humoral Response Against Epithelial Cell Entry-Mediated Infection in the Primary Infection Setting After Hematopoietic Cell TransplantationDanniel Zamora, Elizabeth M Krantz, Margaret L Green, et al.The Lancet. Infectious Diseases|January 13, 2012
A novel therapeutic cytomegalovirus DNA vaccine in allogeneic haemopoietic stem-cell transplantation: a randomised, double-blind, placebo-controlled, phase 2 trialMohamed A Kharfan-Dabaja, Michael Boeckh, Marissa B Wilck, et al.Bone Marrow Transplantation|May 6, 2025
ELISPOT as a predictor of clinically significant cytomegalovirus infection after hematopoietic cell transplantation in letermovir recipientsDanniel Zamora, Hu Xie, Elizabeth Wong, et al.The New England Journal of Medicine|September 27, 2013
CMX001 to prevent cytomegalovirus disease in hematopoietic-cell transplantationFrancisco M Marty, Drew J Winston, Scott D Rowley, et al.Blood|March 23, 2011
HIV-specific CD8+ T cells from HIV+ individuals receiving HAART can be expanded ex vivo to augment systemic and mucosal immunity in vivoAude G Chapuis, Corey Casper, Steve Kuntz, et al.Journal of Virology|April 7, 2017
Transient Oral Human Cytomegalovirus Infections Indicate Inefficient Viral Spread from Very Few Initially Infected CellsBryan T Mayer, Elizabeth M Krantz, David Swan, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2012
Changes in the soluble mucosal immune environment during genital herpes outbreaksMarla J Keller, Rebecca P Madan, Gail Shust, et al.Annals of Internal Medicine|November 17, 2005
The relationship between condom use and herpes simplex virus acquisitionAnna Wald, Andria G M Langenberg, Elizabeth Krantz, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 7, 2024
Therapeutic Targeting of TIM-4-L with Engineered T Cells for Acute Myeloid LeukemiaBrandon Cieniewicz, Edson Oliveira, Mike Saxton, et al.Pageof 75